{{Rsnum
|rsid=2431238
|Gene=APC
|Chromosome=5
|position=112788672
|Orientation=plus
|GMAF=0.258
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene_s=APC
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 45.1 | 49.6 | 5.3
| HCB | 82.1 | 17.2 | 0.7
| JPT | 81.4 | 16.8 | 1.8
| YRI | 47.2 | 45.1 | 7.6
| ASW | 59.6 | 33.3 | 7.0
| CHB | 82.1 | 17.2 | 0.7
| CHD | 74.8 | 21.5 | 3.7
| GIH | 56.6 | 41.4 | 2.0
| LWK | 45.9 | 42.2 | 11.9
| MEX | 60.3 | 32.8 | 6.9
| MKK | 46.8 | 40.3 | 13.0
| TSI | 37.0 | 44.0 | 19.0
| HapMapRevision=28
}}{{PMID Auto
|PMID=20056645
|Title=Association of mitotic regulation pathway polymorphisms with pancreatic cancer risk and outcome
|OA=1
}}

{{omim
|id=114500
|rsnum=2431238
}}

{{ClinVar
|rsid=2431238
|Reversed=0
|FwdREF=T
|FwdALT=C
|REF=T
|ALT=C
|RSPOS=112124369
|CHROM=5
|GMAF=0.2578
|dbSNPBuildID=100
|SSR=0
|SAO=1
|VP=0x05016800000017051f110100
|GENEINFO=APC:324
|GENE_NAME=APC
|GENE_ID=324
|WGT=0
|VC=SNV
|CLNALLE=1
|CLNHGVS=NC_000005.9:g.112124369T>C
|CLNORIGIN=0
|CLNSIG=255
|CLNCUI=114500
|CLNDBN=Familial colorectal cancer
|Tags=PM;PMC;SLO;VLD;G5A;G5;HD;GNO;KGPhase1;KGPilot123;KGPROD;OTHERKG;PH3;LSD;OM
|CAF=0.258; 0.742
|CLNDSDB=GeneReviews:MedGen:OMIM
|CLNDSDBID=NBK1211:CN029768:114500
|COMMON=1
|Disease=Familial colorectal cancer
|CLNACC=RCV000073969.1
}}

{{PMID Auto
|PMID=18708403
|Title=Association of genetic variation in genes implicated in the beta-catenin destruction complex with risk of breast cancer.
|OA=1
}}

{{PMID Auto
|PMID=19777185
|Title=Association analysis of Wnt pathway genes on prostate-specific antigen recurrence after radical prostatectomy.
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Illumina Human 1M}}